LIFECORE BIOMEDICAL, INC. \DE\ Logo

LIFECORE BIOMEDICAL, INC. \DE\

A CDMO for parenteral drugs, producing injectable-grade sodium hyaluronate (HA).

LFCR | NDAQ

Overview

Corporate Details

ISIN(s):
US5147661046
LEI:
Country:
United States of America
Address:
3515 LYMAN BOULEVARD, 55318 CHASKA
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Lifecore Biomedical, Inc. is a fully integrated Contract Development and Manufacturing Organization (CDMO) and a producer of premium, injectable-grade sodium hyaluronate (HA). The company provides end-to-end services for pharmaceutical and medical device partners, including specialty formulation, aseptic filling, process development, and analytical and stability services for parenteral drug products. Lifecore specializes in complex and highly viscous formulations filled into syringes, vials, and cartridges. Its non-animal-sourced sodium hyaluronate is used as an active pharmaceutical ingredient (API) for research, clinical, and commercial applications. With over 40 years of experience, the company supports clients from early-stage development through to commercial-scale manufacturing.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all LIFECORE BIOMEDICAL, INC. \DE\ filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for LIFECORE BIOMEDICAL, INC. \DE\

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for LIFECORE BIOMEDICAL, INC. \DE\ via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
AprilBio Co.,Ltd. Logo
Develops long-acting biologic drugs for autoimmune diseases and oncology using its SAFA™ platform.
South Korea 397030
Aprogen Biologics Inc. Logo
Develops and manufactures novel biologic drugs and biosimilars for the professional market.
South Korea 003060
Aprogen, Inc Logo
Develops and manufactures novel biologics and biosimilars for cancer and arthritis treatments.
South Korea 007460
Develops drugs for fibrosis, inflammation, and cancer using NOX inhibitor & CAF modulation tech.
South Korea 293780
Aptahem AB Logo
Develops RNA aptamers to treat acute, life-threatening conditions like sepsis.
Sweden APTA
Aptamer Sciences Inc Logo
Develops aptamer-based therapeutics and diagnostics for oncology and solid tumors.
South Korea 291650
Aptevo Therapeutics Inc. Logo
Developing multi-specific antibody immunotherapies for hematologic and solid tumor cancers.
United States of America APVO
Aptorum Group Ltd Logo
Biopharma developing novel therapeutics for oncology, infectious and metabolic diseases.
United States of America APM
Aquestive Therapeutics, Inc. Logo
Develops oral film drugs for CNS disorders and severe allergies.
United States of America AQST
Arbutus Biopharma Corp Logo
A clinical-stage virology company developing a functional cure for chronic hepatitis B (HBV).
United States of America ABUS

Talk to a Data Expert

Have a question? We'll get back to you promptly.